References
- Delmas P D. Biochemical markers of bone turnover. J. Bone Min Res 1993; 8: S549–55
- Christiansen C, Riis B J, Rødbro P. Screening procedure for women at risk of developing postmenopausal osteoporosis. Osteoporosis Int 1990; 1: 35–40
- Sørensen O H, Nielsen S P, Thode J, Eriksen E F. Osteoporoseprofil - en darlig undersøgelse?. Ugeskr Láger 1994; 156: 5503–5505
- Blumsohn A, Eastell R. Prediction of bone loss in postmenopausal women. Eur J Clin Invest 1992; 22: 764–66
- Eastell R, Simmons P S, Colwell A, Assir A MA, Burritt M F, Russell G G, et al. Nyctohemeral changes in bone turnover assessed by serum bone Gla-protein concentration and urinary deoxypyridinoline excretion: effects of growth and ageing. Clinical Science 1992; 83: 375–382
- Vanderschueren D, Gevers G, Raymaekers G, Devos P, Dequeker J. Sex- and agerelated changes in bone and serum osteocalcin. Calcif Tissue Int 1990; 46: 179–182
- TremilJieres F A, Pouilles J-M, Ribot C. Vertebral postmenopausal bone loss is reduced in overweight women: a longitudinal study in 155 early postmenopausal women. J Clin Endocrinol Metab 1993; 77: 683–6
- Michaelsen K F, Astrup A, Mosekilde L, Richelsen B, Schroll M, Sørensen O H. Ernaeringens betydning for forebyggelse af knogleskørhed, En rapport fra Ernxringsrådet
- Holbrook T L, Barrett-Connor E. A prospective study of alcohol consumption and bone mineral density. BMJ 1993; 306: 1506–9
- Eriksen E F, Steiniche T, Mosekilde L, Melsen F. Histomorphometric analysis of bone in metabolic bone disease. Endocrinology and metabolism clinics of North America 1989; 118: 919–55
- Glerup H, Eriksen E F, Mosekilde L. Glukokortikoidinduceret osteopeni. Ugeskr Larger 1994; 156: 5489–5494
- Forwood M R, Burr D B. Physical activity and bone mass: exercises in futility?. Bone & Min 1993; 21: 89–112
- Schlemmer A, Hassager C, Jensen S B, Christiansen C. Marked diurnal variation in urinary excretion of pyridinium cross-links in premenopausal women. J Clin Endocrinol Metab 1992; 74: 476–80
- Nielsen H K. Orcadian and circatrigentan changes in osteoblastic activity assessed by serum osteocalcin. Lægeforeningens forlag 1993
- Editorial: New biomarkers of bone resorption. J Clin Endocrinol Metab 1992; 74: 470A-C
- Fraser C G, Harris E K. Generation and application of data on biological variation in clinical chemistry. Critical reviews in clinical laboratory sciences 1989; 27: 409–37
- Harris E K. Effects of intra- and interindividual variation on the appropriate use of normal ranges. Clin Chem 1974; 20: 1535–42
- Magid E, Petersen P H, Christensen M. A note on the theory of reference changes. Scand J Clin Lab Invest 1992; 52(Suppl 208)95–101
- Kollerup G, Thamsborg G, Bhatia H, Sørensen O H. Quantitation of urinary hydroxypuridinium cross-links from collagen by high-performance liquid chromatography. Schand J Clin Lab Invest 1992; 52: 657–662
- Kivirikko K I, Laitinen O, Prockop D J. Modification of a specific assay for hydroxyproline in urine. Analut Biochem 1967; 19: 249–55
- Gowans E LS, Fraser C G. Biological variation in analyte concentrations in urine of apparently healthy men and women. Clin Chem 1987; 33: 847–50
- Fraser C G, Cummings S T, Wilkinson S P, Neville R G, Know J DE, Ho O, et al. Biological variability of 26 clinical chemistry analytes in elderly people. Clin Chem 1989; 35: 783–86
- Fraser C G. Appendix: data on biological variations, 1981 to 1987. Arch Pathol Lab Med 1988; 112: 410–15
- McLaren A M, Isdale A H, Whiting P H, Bird H A, Robins S P. Physiological variations in the urinary excretion of pyridinium crosslinks of collagen. British J Theum 1993; 32: 307–12